PL1704860T3 - Pochodne benzamidyny do leczenia i zapobiegania zapaleniu śluzówki - Google Patents
Pochodne benzamidyny do leczenia i zapobiegania zapaleniu śluzówkiInfo
- Publication number
- PL1704860T3 PL1704860T3 PL05102423T PL05102423T PL1704860T3 PL 1704860 T3 PL1704860 T3 PL 1704860T3 PL 05102423 T PL05102423 T PL 05102423T PL 05102423 T PL05102423 T PL 05102423T PL 1704860 T3 PL1704860 T3 PL 1704860T3
- Authority
- PL
- Poland
- Prior art keywords
- mucositis
- benzamidine derivatives
- prevention
- treatment
- epitelium
- Prior art date
Links
- 206010028116 Mucosal inflammation Diseases 0.000 title abstract 4
- 201000010927 Mucositis Diseases 0.000 title abstract 4
- 150000003937 benzamidines Chemical class 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 210000004876 tela submucosa Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05102423A EP1704860B1 (en) | 2005-03-24 | 2005-03-24 | Benzamidine derivatives for treatment and prevention of mucositis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1704860T3 true PL1704860T3 (pl) | 2011-04-29 |
Family
ID=35058092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05102423T PL1704860T3 (pl) | 2005-03-24 | 2005-03-24 | Pochodne benzamidyny do leczenia i zapobiegania zapaleniu śluzówki |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080194877A1 (pl) |
| EP (1) | EP1704860B1 (pl) |
| JP (1) | JP5020227B2 (pl) |
| AT (1) | ATE485819T1 (pl) |
| AU (1) | AU2006226390B2 (pl) |
| CA (1) | CA2600773C (pl) |
| DE (1) | DE602005024357D1 (pl) |
| DK (1) | DK1704860T3 (pl) |
| ES (1) | ES2351665T3 (pl) |
| PL (1) | PL1704860T3 (pl) |
| PT (1) | PT1704860E (pl) |
| WO (1) | WO2006100204A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100190735A1 (en) * | 2006-03-28 | 2010-07-29 | Myrex Pharmaceuticals Inc. | Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis |
| US20090092574A1 (en) | 2006-12-29 | 2009-04-09 | Scott Richard W | Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof |
| TWI520951B (zh) * | 2011-05-16 | 2016-02-11 | 塞爾西優蒂克斯公司 | 用於治療粘膜炎的化合物 |
| FR2979241B1 (fr) | 2011-08-30 | 2014-05-09 | Nutrialys Medical Nutrition Sa | Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux |
| EP2852571A4 (en) * | 2012-05-23 | 2015-11-25 | Cellix Bio Private Ltd | COMPOSITIONS AND METHOD FOR THE TREATMENT OF MUCOSITIS |
| RU2646823C2 (ru) | 2013-08-19 | 2018-03-07 | Энзикем Лайфсайенсиз Корпорейшн | Композиция для предотвращения или лечения ревматоидного артрита, содержащая в качестве активного ингредиента моноацетилдиглицерид |
| TW201609086A (zh) | 2014-05-15 | 2016-03-16 | 安塞全生命科學公司 | 白血球減少症和血小板減少症之治療方法 |
| US9808438B2 (en) * | 2015-11-09 | 2017-11-07 | Enzychem Lifesciences Corporation | Method for treating mucositis |
| US12268672B2 (en) | 2018-10-23 | 2025-04-08 | Japan Science And Technology Agency | PPARδ activator |
| US11771694B2 (en) | 2020-06-05 | 2023-10-03 | Innovation Pharmaceuticals Inc. | Arylamide compounds for treatment and prevention of viral infections |
| JP7728367B2 (ja) | 2021-06-14 | 2025-08-22 | スコーピオン・セラピューティクス・インコーポレイテッド | がんを処置するために使用され得る尿素誘導体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458777B1 (en) * | 1998-03-13 | 2002-10-01 | Mucosal Therapeutics Llc | Methods and compositions for treating and preventing mucositis |
| ITTO20010110A1 (it) * | 2001-02-08 | 2002-08-08 | Rotta Research Lab | Nuovi derivati benzamidinici dotati di attivita' anti-infiammatoria ed immunosoppressiva. |
-
2005
- 2005-03-24 PL PL05102423T patent/PL1704860T3/pl unknown
- 2005-03-24 DE DE602005024357T patent/DE602005024357D1/de not_active Expired - Lifetime
- 2005-03-24 ES ES05102423T patent/ES2351665T3/es not_active Expired - Lifetime
- 2005-03-24 PT PT05102423T patent/PT1704860E/pt unknown
- 2005-03-24 DK DK05102423.0T patent/DK1704860T3/da active
- 2005-03-24 AT AT05102423T patent/ATE485819T1/de active
- 2005-03-24 EP EP05102423A patent/EP1704860B1/en not_active Expired - Lifetime
-
2006
- 2006-03-16 WO PCT/EP2006/060789 patent/WO2006100204A1/en not_active Ceased
- 2006-03-16 AU AU2006226390A patent/AU2006226390B2/en not_active Ceased
- 2006-03-16 CA CA2600773A patent/CA2600773C/en not_active Expired - Fee Related
- 2006-03-16 JP JP2008502382A patent/JP5020227B2/ja not_active Expired - Fee Related
- 2006-03-16 US US11/909,287 patent/US20080194877A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2600773A1 (en) | 2006-09-28 |
| EP1704860B1 (en) | 2010-10-27 |
| AU2006226390A1 (en) | 2006-09-28 |
| DE602005024357D1 (de) | 2010-12-09 |
| ES2351665T3 (es) | 2011-02-09 |
| JP5020227B2 (ja) | 2012-09-05 |
| WO2006100204A1 (en) | 2006-09-28 |
| EP1704860A1 (en) | 2006-09-27 |
| AU2006226390B2 (en) | 2011-09-08 |
| CA2600773C (en) | 2013-06-11 |
| ATE485819T1 (de) | 2010-11-15 |
| JP2008534471A (ja) | 2008-08-28 |
| US20080194877A1 (en) | 2008-08-14 |
| DK1704860T3 (da) | 2011-02-07 |
| HK1095285A1 (en) | 2007-05-04 |
| PT1704860E (pt) | 2010-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL307201A (en) | Triazine derivatives and their use in cancer treatment. | |
| WO2004093831A3 (en) | Cytokine-expressing cellular vaccine combinations | |
| WO2004073630A3 (en) | Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors | |
| ZA200802872B (en) | Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders | |
| PL1868614T3 (pl) | Schemat dawkowania do leczenia urazowego uszkodzenia mózgu progesteronem | |
| AU2003249356A8 (en) | Safe and effective nutritional supplement formulatins and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods | |
| WO2000035475A3 (de) | Verfahren zur behandlung von cerebralen ischämien sowie verwendung von erythropoietin oder erythropoietin-derivaten zur behandlung von cerebralen ischämien | |
| WO2016025635A3 (en) | Combination therapy for treating cancer | |
| IL173123A0 (en) | System and method for the photodynamic treatment of burns, wounds, and related skin disorders | |
| WO2004096216A3 (en) | Use of a topical medicament comprising riluzole | |
| PL1704860T3 (pl) | Pochodne benzamidyny do leczenia i zapobiegania zapaleniu śluzówki | |
| WO2008133928A3 (en) | Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders | |
| WO2016043874A3 (en) | Combination therapy for treating cancer | |
| PL2083837T3 (pl) | Terapeutyczne zastosowanie co najmniej jednej neurotoksyny botulinowej do leczenia bólu wywołanego co najmniej jednym środkiem przeciwnowotworowym | |
| EP4327873A3 (en) | Tpp1 formulations and methods for treating cln2 disease | |
| ZA200703697B (en) | Use of ranolazone in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure | |
| SG10202002898RA (en) | A Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-Related Disease And A Method For Treating Or Preventing A C5-Related Disease | |
| WO2008045378A3 (en) | Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin | |
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| GB202317288D0 (en) | Pyrrolopyridone derivatives useful in the treatment of cancer | |
| IL282718A (en) | Compounds for use in the treatment or prevention of pain, inflammation and/or autoimmune diseases | |
| WO2006102375A3 (en) | Methods for avoiding edema in the treatment or prevention of pparϝ-responsive diseases, including cancer | |
| TW200724146A (en) | Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant | |
| BRPI0503827A (pt) | métodos para prevenir ou tratar infecções respiratórias em lactentes | |
| GB0425633D0 (en) | Topical formulations for use in the treatment or prevention of dermatological conditions |